Golden
Pherecydes Pharma

Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.

Funding

Series A

On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.

Series B

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.

Timeline

2006

Pherecydes Pharma was founded.

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date

Biotech raises funds to help produce phage therapies for bacterial infections

epmmagazine

Web

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References